Board of directors

Mr. Shang-Hung Shen, Director

Mr. Shen is serving as the Chairman of TA YA Electrical Wire and Cable Co., a reputable, very established company in the field. He is also serving as the Chairman of TA YA Venture Capital Co. Before assuming the Chairmanship in TA YA, he worked as a manager in AT&T.
TA YA Venture placed all investments in communication industry and green energy in earlier periods, but has shifted half of the capital to biotech and pharmaceutical industry in recent years. Mr. Shen emphasizes nurturing corporate culture and employees’ health/welfare and education.

Mr. James C. Ho, Director

Mr. Ho is Chairman of CDIB Capital Management Co. and brings ~ 30 years of experience in industrial policy, investment, and corporate operations. He has served as Chairman of PharmaEngine, Inc., and as a director or supervisor of companies including CDIB, Andes Technology, and TSMC.
As Deputy Executive Secretary of the National Development Fund, he led strategic investments in biotechnology and priority industries, supporting numerous Taiwanese companies, over 80% of which successfully completed public listings.

Mr. Jung-Chin Lin, Director

He has over the last 20 years transformed the Center Laboratories Inc. into a biotech and pharmaceutical investment house with a diverse portfolio, including Mycenax Biotech, Lumosa Therapeutics, Adimmune Corp., TOT Biopharma, Jacobio Pharmaceutical Group, and many others. Mr. Lin serves as a chairman, director, advisor in many of his portfolio companies. He values innovative technologies and envisions antibody drug conjugates, cell therapy, and genetic therapy to play import roles in pharmaceutical industry.

Ms. Audrey Tseng, Director

Ms. Tseng is an Honorary Deputy Chairman of PwC Taiwan, a member of BioTaiwan Committee, an advisor to BioTReC of Academia Sinica, and an advisor to Ministry of Health and Welfare. With over 35 years of experience as a Taiwan-licensed CPA, she has assisted numerous biopharma and medtech companies in financial management and public listing in Taiwan. She has also served advisory roles for some of these companies to go IPO in overseas markets.

Mr. William Hung, Director

Mr. Hung has more than 25 years of experience in healthcare industry. He served as a CEO, director, supervisor, or executive in Tanvex Taiwan, CHC Healthcare Holding, Swissray Global, H&Q APBME and several VC firms, and hospitals in Taiwan and abroad. In such roles he was responsible for helping the organizations with founding, investment, management, IPO, and M&A activities. Recently, he was appointed as an advisor by National Cheng Kung University and the National Biotechnology Research Park to promote academia–industry collaboration and new venture development.